Mette Julsgaard (M Julsgaard)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

Journal of Crohn's & colitis

Gut

Aarhus Univesity Hospital

Aarhus University Hospital (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aarhus Univesity Hospital

Denmark

MD, PhD :: Hepatology and Gastroenterology V

St. Vincents Hospital Nov 01 2011 - May 14 2012

Australia

Honorary Research Fellow :: Gastroenterology

Education History

Aarhus University Hospital - Jun 19 2014

Denmark

PHD :: Hepatology and Gastroenterology V

Publications

Linéa Bonfils, Gry Poulsen, Manasi Agrawal, Mette Julsgaard, Joanna Torres, Tine Jess, Kristine Højgaard Allin
Impact of prenatal and postnatal maternal IBD status on offspring's risk of IBD: a population-based cohort study. Gut (2024)
Cæcilie Skejø, Signe Thim, Anna Sellmer, Mette Julsgaard
Early Onset Sepsis and Lobar Pneumonia in a Newborn Exposed In Utero to Ustekinumab and Azathioprine. Inflammatory bowel diseases 30 (2) (2024)
María José García, Sabino Riestra, Aurélien Amiot, Mette Julsgaard, Irene García de la Filia, Margalida Calafat, Mariam Aguas, Luisa de la Peña, Cristina Roig, Berta Caballol, María José Casanova, Klaudia Farkas, Trine Boysen, Luis Bujanda, Camila Cuarán, Daniela Dobru, Fotios Fousekis, Carla Jerusalén Gargallo-Puyuelo, Edoardo Savarino, Xavier Calvet, Jose Maria Huguet, Limas Kupcinskas, Julia López-Cardona, Tim Raine, Joep van Oostrom, Francisco Javier García-Alonso, Maria Chaparro
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). Alimentary pharmacology & therapeutics 59 (10) (2024)
Femke Crouwel, Melek Simsek, Marjon A de Boer, Dirk P van Asseldonk, Abha Bhalla, Angelique L M Weusthuis, Lennard P L Gilissen, Robert J Verburg, Wout G N Mares, Bindia Jharap, Johan P Kuijvenhoven, Bas Oldenburg, Hans J C Buiter, Mette Julsgaard, Nanne K de Boer
Multicentre study and systematic review: Allopurinol exposure during pregnancy. Alimentary pharmacology & therapeutics (2024)
Femke Crouwel, Melek Simsek, Marjon A de Boer, Dirk P van Asseldonk, Abha Bhalla, Angelique L M Weusthuis, Lennard P L Gilissen, Robert J Verburg, Wout G N Mares, Bindia Jharap, Johan P Kuijvenhoven, Bas Oldenburg, Hans J C Buiter, Mette Julsgaard, Nanne K de Boer
Multicentre study and systematic review: Allopurinol exposure during pregnancy. Alimentary pharmacology & therapeutics 60 (4) (2024)
María José García, Sabino Riestra, Aurélien Amiot, Mette Julsgaard, Irene García de la Filia, Margalida Calafat, Mariam Aguas, Luisa de la Peña, Cristina Roig, Berta Caballol, María José Casanova, Klaudia Farkas, Trine Boysen, Luis Bujanda, Camila Cuarán, Daniela Dobru, Fotios Fousekis, Carla Jerusalén Gargallo-Puyuelo, Edoardo Savarino, Xavier Calvet, Jose Maria Huguet, Limas Kupcinskas, Julia López-Cardona, Tim Raine, Joep van Oostrom, Francisco Javier García-Alonso, Maria Chaparro
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). Alimentary pharmacology & therapeutics 59 (10) (2024)
Femke Crouwel, Melek Simsek, Marjon A de Boer, Dirk P van Asseldonk, Abha Bhalla, Angelique L M Weusthuis, Lennard P L Gilissen, Robert J Verburg, Wout G N Mares, Bindia Jharap, Johan P Kuijvenhoven, Bas Oldenburg, Hans J C Buiter, Mette Julsgaard, Nanne K de Boer
Multicentre study and systematic review: Allopurinol exposure during pregnancy. Alimentary pharmacology & therapeutics 60 (4) (2024)
María José García, Sabino Riestra, Aurélien Amiot, Mette Julsgaard, Irene García de la Filia, Margalida Calafat, Mariam Aguas, Luisa de la Peña, Cristina Roig, Berta Caballol, María José Casanova, Klaudia Farkas, Trine Boysen, Luis Bujanda, Camila Cuarán, Daniela Dobru, Fotios Fousekis, Carla Jerusalén Gargallo-Puyuelo, Edoardo Savarino, Xavier Calvet, Jose Maria Huguet, Limas Kupcinskas, Julia López-Cardona, Tim Raine, Joep van Oostrom, Francisco Javier García-Alonso, Maria Chaparro
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). Alimentary pharmacology & therapeutics (2024)
Thea Vestergaard, Ida Holm Meiltoft, Mette Julsgaard, Rikke Bek Helmig, Sonia Friedman, Jens Kelsen
Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD. Inflammatory bowel diseases (2024)
Linéa Bonfils, Gry Poulsen, Manasi Agrawal, Mette Julsgaard, Joanna Torres, Tine Jess, Kristine Højgaard Allin
Impact of prenatal and postnatal maternal IBD status on offspring's risk of IBD: a population-based cohort study. Gut (2024)
Davide Giuseppe Ribaldone, Sophie Vieujean, Mette Julsgaard, Angelo Armandi, Fabiana Zingone, Edoardo Savarino, Fiorella Cañete, Annalisa Aratari, Nicola Imperatore, Laura Ramos, Rocio Plaza, Daniela Pugliese, Brigida Barberio, David Drobne, María Chaparro
Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER Multicentre Case Series. Journal of Crohn's & colitis (2023)
Thea Vestergaard, Jens Kelsen, Mette Julsgaard
Specialized Prenatal Care for Women With IBD Makes a Difference. Inflammatory bowel diseases (2023)
Cæcilie Skejø, Signe Thim, Anna Sellmer, Mette Julsgaard
Early Onset Sepsis and Lobar Pneumonia in a Newborn Exposed In Utero to Ustekinumab and Azathioprine. Inflammatory bowel diseases (2023)
Thea Vestergaard, Julie Røsok, Mette Julsgaard, Rikke Bek Helmig, Sonia Friedman, Jens Kelsen
Time to Diagnosis and Birth Outcomes of Pregnancy-onset IBD. Inflammatory bowel diseases (2023)
Thea Vestergaard, Jens Kelsen, Mette Julsgaard
Editorial: predictors of disease activity during pregnancy in women with inflammatory bowel disease - a Danish cohort study. Authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Thea Vestergaard, Jens Kelsen, Mette Julsgaard
Editorial: predictors of disease activity during pregnancy in women with inflammatory bowel disease - a Danish cohort study. Authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Liselotte Fierens, Nicholas Carney, Gottfried Novacek, C Janneke van der Woude, Britta Siegmund, Francesc Casellas, Natalia Borruel, Anouk S Huberts, Elena Sonnenberg, Nathalie Gerold, Christian Primas, Charlotte Rose Hedin, Tanja Stamm, Mette Julsgaard, Gionata Fiorino, Radice Simona, Michela Luciana Luisa Zini, Evelyn Gross, Cornelia Sander, Ingrid Arijs, Vasiliki-Rafaela Vakouftsi, Tunde Koltai, null null, null null, Iliàs Charlafti, Marc Ferrante
A Core Outcome Set for inflammatory bowel diseases: development and recommendations for implementation in clinical practice through an international multi-stakeholder consensus process. Journal of Crohn's & colitis (2023)
Jantien W Wieringa, Matthijs D Kruizinga, Gertjan J A Driessen, C Janneke van der Woude, Mette Julsgaard
Validation of the pharmacokinetic model for anti- TNFα clearance in infants exposed to anti- TNFα during pregnancy. Journal of Crohn's & colitis (2023)
Zheng Liu, Mette Julsgaard, Xiao Zhu, Jennifer Martin, Murray L Barclay, Noel Cranswick, Peter R Gibson, Richard B Gearry, Janine van der Giessen, Susan J Connor, Ourania Rosella, Anne Grosen, Catherine Toong, Emma K Flanagan, Jantien W Wieringa, C Janneke van der Woude, Sally J Bell, null null
Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children. Journal of Crohn's & colitis 16 (12) (2022)
Anne Grosen, Emanuelle Bellaguarda, Ingela Liljeqvist-Soltic, Mette Mejlby Hansen, Anne-Bine Skytte, Mette Julsgaard, Stephen B Hanauer, Jens Kelsen
Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy. Inflammatory bowel diseases 28 (10) (2022)
Maria Chaparro, Lumir Kunovsky, Mariam Aguas, Moran Livne, Pauline Riviere, Ariella Bar-Gil Shitrit, Pär Myrelid, Maite Arroyo, Manuel Barreiro-de Acosta, Michelle Bautista, Livia Biancone, Irit Avni Biron, Trine Boysen, Daniel Carpio, Beatriz Castro, Gabriele Dragoni, Pierre Ellul, Stefan D Holubar, Miguel Ángel de Jorge, Eduardo Leo, Noemí Manceñido, Annick Moens, Tamás Molnár, Patricia Ramírez de la Piscina, Petr Ricanek, Ladislava Sebkova, Laura Sempere, Niels Teich, Javier P Gisbert, Mette Julsgaard
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]. Journal of Crohn's & colitis 16 (9) (2022)
Thea Vestergaard, Mette Julsgaard, Julie F Røsok, Søren V Vestergaard, Rikke B Helmig, Sonia Friedman, Jens Kelsen
Predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study. Alimentary pharmacology & therapeutics 57 (3) (2022)
Thea Vestergaard, Mette Julsgaard, Julie F Røsok, Søren V Vestergaard, Rikke B Helmig, Sonia Friedman, Jens Kelsen
Predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study. Alimentary pharmacology & therapeutics 57 (3) (2022)
Caecilie Skejø, Thea Vestergaard, Mette Julsgaard
Editorial: safety of ustekinumab in pregnancy-are we there yet? Alimentary pharmacology & therapeutics 55 (4) (2022)
Thea Vestergaard, Mette Julsgaard, Julie F Røsok, Søren V Vestergaard, Rikke B Helmig, Sonia Friedman, Jens Kelsen
Predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study. Alimentary pharmacology & therapeutics (2022)
Thea Vestergaard, Mette Julsgaard, Julie F Røsok, Søren V Vestergaard, Rikke B Helmig, Sonia Friedman, Jens Kelsen
Predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study. Alimentary pharmacology & therapeutics 57 (3) (2022)
Thea Vestergaard, Mette Julsgaard, Julie F Røsok, Søren V Vestergaard, Rikke B Helmig, Sonia Friedman, Jens Kelsen
Predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study. Alimentary pharmacology & therapeutics 57 (3) (2022)
Joanna Torres, María Chaparro, Mette Julsgaard, Konstantinos Katsanos, Zuzana Zelinkova, Manasi Agrawal, Sandro Ardizzone, Marjo J E Campmans-Kuijpers, Gabriele Dragoni, Marc Ferrante, Gionata Fiorino, Emma K Flanagan, Catarina Geraldes de Frias Gomes, Ailsa Hart, Charlotte Rose Hedin, Pascal Juillerat, Annemarie Mulders, Pär Myrelid, Aoibhlinn O'Toole, Pauline Riviere, Michael Scharl, Christian Philipp Selinger, Elena Sonnenberg, Murat Toruner, Jantien Wieringa, C Janneke Van der Woude
European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. Journal of Crohn's & colitis (2022)
Mette Julsgaard, Daniel C Baumgart, Simon Mark Dahl Jørgensen, Mette M Hansen, Anne Grosen, Bo M Bibby, Niels Uldbjerg, Jens Kjeldsen, Heidi G Sørensen, Lone Larsen, Signe Wildt, Petra Weimers, Kent V Haderslev, Ida Vind, Lise Svenningsen, Jørn Brynskov, Søren Lyhne, Thea Vestergaard, Christian L Hvas, Jens Kelsen, null null
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study. Alimentary pharmacology & therapeutics 54 (10) (2021)
Michael B MacIsaac, Mette Julsgaard, Emma Flanagan, Stephanie Rowe, Alyson L Ross, Richard B Gearry, Peter R Gibson, Sally J Bell
Anti-TNFα Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series. Inflammatory bowel diseases (2021)
Camilla Rye, Katrine Hass Rubin, Frederik Trier Møller, Mette Julsgaard, Tine Jess, Vibeke Andersen
Positive Predictive Value of Diagnostic Codes for Inflammatory Bowel Disease in the Danish National Patient Registry Among Individuals 50+ Years, Using Patient Records as Reference Standard. Clinical epidemiology 13 (2021)
Mette Julsgaard, J Kjeldsen, B Brock, Daniel C Baumgart
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease. Alimentary pharmacology & therapeutics 48 (3) (2019)
Steffen Bank, Mette Julsgaard, Osama Karim Abed, Burisch J, Jacob Broder Brodersen, Natalia Konstantinovich Pedersen, Anja Gouliaev, Rullah Ajan, Ditlev Nytoft Rasmussen, Camilla Honore Grauslund, Stine Roug, Julie Galsgaard, David Sprogøe Høyer Finsen, Karoline Lindby, null null, Jeanette Sørensen, Lone Larsen, Malene Rohr Andersen, Ivan Brandslund, Mads Thomassen, Anders Green, Anders Bo Bojesen, Signe Bek Sørensen, Ulla Vogel, Vibeke Andersen
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 49 (7) (2019)
Annick Moens, C Janneke van der Woude, Mette Julsgaard, Evelien Humblet, Juliette Sheridan, Daniel C Baumgart, Cyrielle Gilletta De Saint-Joseph, Stéphane Nancey, Jean-François Rahier, Peter Bossuyt, Anneline Cremer, Sophie Dewit, Carl Eriksson, Frank Hoentjen, Thomas Krause, Edouard Louis, Elisabeth Macken, Zoran Milenkovic, Jochen Nijs, Annelies Posen, Anneleen Van Hootegem, Wouter Van Moerkercke, Séverine Vermeire, Ariella Bar-Gil Shitrit, Marc Ferrante
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Alimentary pharmacology & therapeutics 51 (1) (2019)

Mette Julsgaard (M Julsgaard)

Publication Activity (10 Years)

Top Topics

Top Venues